A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2002
08/29/2002	US20020119961 Bridged piperazine derivatives
08/29/2002	US20020119956 Using thalidomine
08/29/2002	US20020119949 Prophylactic teat treatment
08/29/2002	US20020119946 Formative agent of protein complex
08/29/2002	US20020119926 Inhibitors of IAPP fibril formation and uses thereof
08/29/2002	US20020119924 Combination therapy using a TNF binding protein for treating TNF-mediated diseases
08/29/2002	US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
08/29/2002	US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders
08/29/2002	US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease
08/29/2002	US20020119207 For decontaminating areas, samples, solutions, and foodstuffs colonized or otherwise infected by pathogens and microorganisms
08/29/2002	US20020119206 Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions
08/29/2002	US20020119198 For manufacture of a medicament for therapeutic treatment, such as steroidal, antifungal, antibacterial, or anticancer treatment
08/29/2002	US20020119196 May be used to make chewable tablets or rapidly disintegrating tablets that conveniently may be administered without water
08/29/2002	US20020119187 Useful to induce analgesia
08/29/2002	US20020119164 Use of agaricus blazei murill to prevent or treat skin and other disorders
08/29/2002	US20020119159 Administering to a mucosal surface inducing antigen and mucosal binding component in unconjugated form for inducing sustained immunological tolerance in an individual to a target antigen
08/29/2002	US20020119104 Treatment of mucositis
08/29/2002	DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives
08/29/2002	DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical
08/29/2002	CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
08/29/2002	CA2473197A1 Novel human protease and polynucleotides encoding the same
08/29/2002	CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy
08/29/2002	CA2438711A1 Tryptase inhibitors
08/29/2002	CA2438685A1 Tryptase inhibitors
08/29/2002	CA2438682A1 Antibodies that bind both bcma and taci
08/29/2002	CA2438519A1 Emulsions and aqueous dispersions of phytosterols
08/29/2002	CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
08/29/2002	CA2438312A1 Anthrone derivatives and their use as jnk inhibitors
08/29/2002	CA2438241A1 Medicinal compositions comprising diclofenac and ornoprostil
08/29/2002	CA2438235A1 Neurotransmission-associated proteins
08/29/2002	CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
08/29/2002	CA2437242A1 Tramadol-based medicament
08/29/2002	CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same
08/29/2002	CA2433348A1 Detection of compounds that modulate inflammatory responses
08/29/2002	CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
08/28/2002	EP1234834A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
08/28/2002	EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
08/28/2002	EP1234816A1 Scyphostatin analogues as SMase inhibitors
08/28/2002	EP1234585A2 Methods and compositions for the prevention or treatment of cancer
08/28/2002	EP1234185A2 Pin1 as a marker for abnormal cell growth
08/28/2002	EP1234035A1 Human cytokine receptor
08/28/2002	EP1234034A1 Transfer compounds, the production and the use thereof
08/28/2002	EP1234025A1 Human enzymes of the metalloprotease family
08/28/2002	EP1234024A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
08/28/2002	EP1233975A1 29 human secreted proteins
08/28/2002	EP1233964A1 New use and novel n-azabicyclo-amide derivatives
08/28/2002	EP1233963A2 Novel sulfonyl oxazole amines
08/28/2002	EP1233962A2 Novel heterocyclic compounds and their use as medicines
08/28/2002	EP1233960A2 Polymorphic salt of an anti-migraine drug
08/28/2002	EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
08/28/2002	EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
08/28/2002	EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
08/28/2002	EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands
08/28/2002	EP1233942A2 Treatment of inflammatory bowel disease with vitamin d compounds
08/28/2002	EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
08/28/2002	EP1233781A1 Assays and therapies for latent viral infection
08/28/2002	EP1233779A2 New uses of suppressive macrophage activation factors
08/28/2002	EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233776A1 Urotensin-ii cyclic analogs
08/28/2002	EP1233774A1 Urotensin-ii analogs
08/28/2002	EP1233772A1 Boron compounds and complexes as anti-inflammatory agents
08/28/2002	EP1233771A1 Protease inhibitors
08/28/2002	EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
08/28/2002	EP0983275B1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
08/28/2002	EP0794966B1 Humanized antibodies to cd38
08/28/2002	CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor
08/28/2002	CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor
08/28/2002	CN1365830A Capsule 'Linkangning'
08/28/2002	CN1365821A Medicine 'Huwei Dan' for treating injury and gastroenteropathy
08/28/2002	CN1365811A Nano medicine 'Huixiang Juhe' and its preparing process
08/28/2002	CN1365809A Nano medicine 'Fuke Tongjing' and its preparing process
08/28/2002	CN1365807A Nano medicine 'Kanlisha' and its preparing process
08/28/2002	CN1365804A Nano medicine 'Shensu' and its preparing process
08/28/2002	CN1365803A Nano 7-component Xinxiao medicine and its preparing process
08/28/2002	CN1365799A Nano medicine for treating arthragra and its preparing process
08/28/2002	CN1365796A Nano medicine 'Xiaoer Qingyan' and its preparing process
08/28/2002	CN1365794A Nano medicine 'Xingnaojing' and its preparing process
08/28/2002	CN1365783A Nano medicine 'Shangshi Zhitong' and its preparing process
08/28/2002	CN1365781A Nano medicine 'Ruyi Jinhuang' and its preparing process
08/28/2002	CN1365770A Nano medicine 'Miaoji' and its preparing process
08/28/2002	CN1365769A Nano medicine 'Kanggan' and its preparing process
08/28/2002	CN1365759A Nano antalgic medicine 'Zijin' and its preparing process
08/28/2002	CN1365755A Nano medicine 'Yuzhen' and its preparing process
08/28/2002	CN1365753A Nano medicine 'Yanghe Jiening' and its preparing process
08/28/2002	CN1365751A Nano medicine 'Shaolin' for treating rheumatism, bone fracture and injury and its preparing process
08/28/2002	CN1365750A Nano medicine 'Shaofu Zhuyu' and its preparing process
08/28/2002	CN1365749A Nano medicine 'Xiongju Shangqing' and its preparing process
08/28/2002	CN1365715A Nano medicine 'Jiuqi Niantong' and its preparing process
08/28/2002	CN1365714A Nano medicine 'Jiufen' and its preparing process
08/28/2002	CN1365713A Nano medicine for treating ulcer and its preparing process
08/28/2002	CN1365711A Nano vomiting nut medicine and its preparing process
08/28/2002	CN1365702A Nano medicine for treating infantile convulsion and its preparing process
08/28/2002	CN1365691A Nano medicine 'Kunming begonia' and its preparing process
08/28/2002	CN1365686A Nano clove medicine and its preparing process
08/28/2002	CN1365685A Nano medicine for reating bone fracture and injury and its preparing process
08/28/2002	CN1365675A Nano medicine 'Fuzilizhong' and its preparing process
08/28/2002	CN1365673A Nano medicine 'Fengliaoxing' for treating rheumatism, bone fracture and injury and its preparing process
08/28/2002	CN1365670A Antalgesic liniment
08/28/2002	CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/28/2002	CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide

1 ... 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 ... 1272